Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Gamida Cell Announces $40 Million Private Financing
Financing provides strong base to complete Phase 3 clinical trial and commercialization of lead product candidate NiCord® for blood cancersJerusalem, Israel, June 19, 2017 — Gamida Cell Ltd.
Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled Syringe
SAN DIEGO, June 15, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ.
Novartis, Verily back $300M Medicxi biotech growth fund
Novartis and Verily have helped Medicxi raise $300 million (€268 million) to invest in late-stage drug developers.
Intermediaries capture 41% of price paid for drugs in USA, study shows
In research that should be essential reading for anyone involved in attempts to reduce US drug prices, it has been found that more than 40% of the money spent by consumers on pharmaceuticals goes ...
State attorneys general probe opioid drug companies
A bipartisan group of state attorneys general announced on Thursday that they are jointly investigating the marketing and sales practices of drug companies that manufacture opioid painkillers at the c...
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Earlier this month, industry watchers questioned who could swallow the reportedly on-the-block Tesaro and its $7.
Johnson & Johnson's Type 2 Diabetes Drug Is Stellar in Cardiovascular Trials, but Comes With a Catch
Invokana is a next-generation SGLT-2 inhibitor that has the opportunity to slowly push traditional DPP-4 inhibitors like Merck's (NYSE.
New cancer drug makes commonly prescribed chemo drug more effective when given together
Researchers have found a way to increase the effectiveness of a widely used cancer drug while decreasing the risk of heart-damaging side effects, according to a new study by researchers from The Unive...
Johnson & Johnson's flu drug succeeds in mid-stage trial
Diversified healthcare company Johnson & Johnson said on Wednesday its experimental flu drug significantly reduced the presence of the virus in patients with a type of influenza in a mid-stage stu...
Sanofi to invest further in biologics
Sanofi announced plans to invest 600 million euros ($673 million) annually over the next two to three years in the field of biologics production, an area of strong growth potential.
FDA Approves Optical Imaging Agent for Visualization of Malignant Tissue During Gliomas Surgery
On June 6, 2017, the U.
Neglected diabetes candidate may have a future in oncology
Research published in Nature magazine’s Scientific Reports offers hope that a new combination therapy could represent a safer and more effective option for cancer patients.
507
508
509
510
511
512
513
514
515
